Chefs in Action

Chefs In Action teaches healthy cooking techniques

When UK HealthCare opened its state-of-the-art dining facility, Chandler Dining, last year, it embraced the concept that food service should be as involved in teaching healthy habits as medical and nursing staff.

The long lines of institutional steamers and shelving to slide plastic trays along were gone, replaced instead with cooking hubs where diners can choose nutritious, freshly prepared food ingredients and have their dish prepared to order before their eyes.

The new facility, which is open to patients, families, staff and the public, offers restaurant-quality food selections that you wouldn’t expect to see in a hospital cafeteria.

Perhaps less expected was a teaching kitchen where chefs can demonstrate healthy meal preparations. UK HealthCare Executive Chef Pete Combs was tasked with creating a platform for sharing with hospital patients, visitors and staff the tips and techniques that make food more nutritious. The result? A monthly series called Chefs in Action.

“Chefs in Action is designed to help people see that it’s not difficult to cook healthy dishes with high-quality ingredients,” said Combs, a food service industry veteran of more than 30 years. “The power of food [in improving health] is huge.”

At 4 p.m. on the third Thursday of every month, Combs and sous chefs Justin Clark and Sarah Null prepare a themed menu with an extra dash of theater and humor. At the February event, the Heart Month-themed menu included:

  • Flaxseed hummus with almond crackers, jicama, rainbow peppers and carrot.
  • Three-bean salsa with avocado, tomato and cucumber chips.
  • Roasted butternut squash boat with asparagus, ginger, almond and wild mushrooms.
  • Rainbow trout stuffed with Fuji apples, walnuts, spinach and raisins with orange saffron sauce.
  • Raspberry banana and dark chocolate bites.

As they demonstrated each recipe and distributed free samples to the audience, dietitians Andrea Francis, Jill Haeberlin and Katie Lewis listed the ingredients in each dish and explained how they boosted heart health.

“Sharing nutrition information is as important as showing people how to make the recipe,” Combs said. “People may not want to make the apple-walnut stuffing, but they might add walnuts to one of their favorite dishes once they learn that walnuts can reduce cardiovascular problems and Type 2 diabetes.”

Housley says the long-term goal for Chefs in Action is to make the demos available to patients via the Get Well Network, an in-room patient engagement system that helps improve the transition of care from hospital to home.

“UK HealthCare is not just about medicine,” said J.J. Housley, UK HealthCare’s director of enterprise operations. “This enterprise strives to provide Kentuckians with the tools for healthy living, and why wouldn’t our food service be a significant player in that effort?”

The next Chefs in Action will be at 4 p.m., this Thursday, April 20.  The menu will center on healthy twists to Kentucky’s classic dishes. No reservations are necessary and the event is free. Check out the video below to learn more about Chefs in Action.


Next steps:

Researchers and health policy leaders from UK discussed how to combat drug abuse during this year's National Rx Drug Abuse and Heroin Summit.

UK brings expertise to national summit on opioid drug crisis

Addiction researchers, clinicians, intervention coordinators and health policy leaders from UK and UK HealthCare are taking part in a national conversation this week focused on combating the opioid drug crisis.

The National Rx Drug Abuse and Heroin Summit, taking place April 17-20 in Atlanta, is the largest national collaboration of professionals from local, state and federal agencies, business, academia, treatment providers, and allied communities impacted by prescription drug abuse and heroin use. It was introduced in 2012 under the leadership of Operation UNITE and U.S. Rep. Harold “Hal” Rogers (KY-5th) with the purpose of alleviating the burden of illegal substance abuse through comprehensive approaches. In this regard, UK leads the way.

Last year alone, investigators in the UK Center on Drug and Alcohol Research received $9.6 million for projects dedicated to substance abuse and addiction. Since 2010, the National Institute on Drug Abuse has awarded more than $92 million to UK research projects. UK HealthCare is proud to support the summit through sponsorship.

“UK is uniquely positioned to confront these questions because of its multidisciplinary research endeavors, leading academic medical center and regional referral network deployed to confront the scourge of opioids. We’re committed to working in – and with – communities to help navigate the complex nature of critical policy changes and effective healthcare implementation,” UK President Eli Capilouto said.

Kentucky’s rate of opioid overdose death remains above the national average, with the Centers for Disease Control and Prevention reporting 1,273 Kentucky overdose deaths in 2015.

“The opioid epidemic is far-reaching and multifaceted, leaving a void in each family and community it scars,” Capilouto said. “Kentucky families and communities throughout Appalachia know the devastation and havoc of addiction. That’s why this question is critical to UK researchers who lead the research, healthcare and policy questions surrounding opioid abuse.”


Next steps:

Kate Zaytseva, one of four project leaders on the COBRE grant for the Center for Cancer and Metabolism, and postdoc Naser Jafari are studying the importance of an enzyme called fatty acid synthase in controlling survival and spread of colorectal cancer.

UK wins $11.2 million NIH grant to study cancer-obesity link

UK has been awarded an $11.2 million grant from the National Institutes of Health to study the link between cancer and metabolic disorders, including obesity. The prestigious award will enable UK to launch the UK Center for Cancer and Metabolism (CCM).

The Centers of Biomedical Research Excellence (COBRE) grant to study the metabolism of cancer comes from the NIH’s National Institutes of General Medical Sciences and will fund the UK Center for Cancer and Metabolism over the next five years.

Kentucky has disproportionately high incidences of both cancer and metabolic disorders – our state leads the nation in cancer deaths and is in the top 10 for highest obesity rates in the country. While scientists have long known of a direct link between obesity and cancer, the need for further research into this field is a necessity for Kentuckians.

Senate Majority Leader Mitch McConnell of Kentucky, an advocate of the 21st Century Cures Act, contacted NIH Director Francis S. Collins on behalf of UK’s grant application.

“In an effort to improve healthcare access and outcomes for my constituents, UK has long made a priority of undertaking important research specific to Kentucky and the Appalachian region,” McConnell said.

“Over the years, UK and its Markey Cancer Center have developed one of the strongest cancer research, prevention and treatment programs in the country, as demonstrated by the center’s 2013 NIH National Cancer Institute designation, which I was proud to support. I was also pleased to assist UK in securing this competitive grant to advance and strengthen this critical health research for Kentucky by enabling advanced research focusing on the development of novel therapies for cancer treatment.”

Kentucky Representative Andy Barr echoed McConnell’s sentiments, noting that support and funding for innovative cancer research remains a priority.

“The awarding of this competitive grant is a recognition of the University of Kentucky as a national leader in biomedical research,” Barr said. “I have consistently supported the National Institutes of Health because these investments not only contribute to our local communities and institutions, they will improve and even save lives by advancing new treatments and cures. I am confident the healthcare services provided by the NCI-designated Markey Cancer Center and the research done by UK scientists funded by this grant will help us to find better ways to fight cancer, which will benefit patients and families in Kentucky and around the world.”

Linking metabolism and cancer

The UK Center for Cancer and Metabolism capitalizes on highly specialized institutional strengths in cancer and advanced metabolomics tools to focus on the underlying mechanisms that link dysfunctional metabolism to cancer. Recent studies have shown that the metabolic powerhouse of cells – the mitochondria – can influence how aggressive a cancer becomes.

UK has internationally renowned experts in the field of cancer and metabolism, and new state-of-the-art technology has improved the ability to understand how metabolism impacts cancer.

“As the University for Kentucky, we are uniquely positioned to conduct this level of sophisticated research thanks to the presence of a diverse array of biomedical researchers, clinicians and our leading academic medical center,” UK President Eli Capilouto said. “Research and development is at the core of economic and human development, and it is why UK is Kentucky’s most instrumental change agent, health provider and economic engine. The progress we make offers the brightest future and best hope for Kentucky.”

The CCM will bring together highly complementary disciplinary strengths at UK in cancer, metabolism and data sciences, coupled with sophisticated metabolomics tools and advanced cancer imaging capabilities, to strengthen the university’s cancer research enterprise by providing a thematically focused multidisciplinary infrastructure dedicated to defining the role of metabolism in the development and treatment of cancer.

“Research is at the heart of any progress we hope to make in bridging health gaps in the Commonwealth,” said Lisa Cassis, UK vice president for research. “Increased funding opportunities through the 21st Century Cures Act, and in particular this COBRE focused on cancer and metabolism, will enable the university to foster the development of the next generation of scientists who will lead our efforts in translating basic research findings into promising new therapies.”

Fighting back against cancer in Kentucky

The scientific discoveries achieved through the CCM will continue to help the UK Markey Cancer Center in its mission to conquer cancer in the Commonwealth. As Markey prepares to renew its National Cancer Institute Cancer Center designation, and simultaneously compete to become a Comprehensive Cancer Center later in 2017, Markey Director Dr. Mark Evers emphasizes the need for increased cancer research funding and continuing to push for new discoveries.

“Nowhere in the country is it more important to have this level of cancer research underway,” Evers said. “Kentuckians face a unique set of health issues, but we at the UK Markey Cancer Center are distinctly positioned to help solve the problem. Being an NCI-designated cancer center means being a leader in research as well as clinical care and outreach. This funding will allow us to translate our findings into potential new therapies for cancer patients from Kentucky and beyond.”

The CCM leverages expertise with mentors and collaborators from across multiple UK centers, disciplines and departments. The multidisciplinary collaboration is indicative of the type of work ongoing at UK and UK HealthCare every day.

“This new funding is another example of the vital importance to the people of Kentucky – and this region – in having an academic medical center at the University of Kentucky,” said Dr. Michael Karpf, UK executive vice president for health affairs. “The synergy and collaboration between researchers and clinicians to further studies in cancer can only be done at a place like this, where people are working together to make a difference in the lives of patients now and for generations to come.”

Promoting collaboration

COBRE grants also use this platform to develop promising early-stage investigators with enhanced skillsets in exciting new areas of cancer research and to enhance their success in competing for NIH grant support. The grant promotes collaborative, interactive efforts among researchers with complementary backgrounds, skills and expertise.

Four junior investigators, mentored by teams of clinicians and scientists from a variety of disciplines, departments, and colleges at UK, will lead major projects investigating an aspect of cancer metabolism:

  • “Role of vitamin D in protecting against cachexia in cancer patients,” led by Travis Thomas, Department of Clinical Sciences, UK College of Health Sciences
  • “Role of serine biosynthesis pathway in breast cancer,” led by Yadi Wu, Department of Pharmacology and Nutritional Sciences, UK College of Medicine
  • “Role of RORα in breast cancer metastasis,” led by Ren Xu, Department of Pharmacology and Nutritional Sciences, UK College of Medicine
  • “Role of fatty acid synthase in colorectal cancer,” led by Kate Zaytseva, Department of Toxicology and Cancer Biology, UK College of Medicine

The CCM is co-led by program directors Daret St. Clair, professor and James Graham Brown Foundation Endowed Chair in the UK Department of Toxicology and Cancer Biology, and Peter Zhou, professor in the UK Department of Molecular and Cellular Biochemistry.

“Having the kind of environment where learning and collaboration are placed at the forefront is why we were chosen for this grant, and we hope to continue that throughout the life of this center,” St. Clair said. “It will also enable us to reach out to new and talented researchers who want to come to UK to become new project leaders and continue the work we’re doing.”


Watch the video below to learn more about the Center for Cancer and Metabolism.


Next steps:

World Voice Day

On World Voice Day, take time to celebrate your voice

JoAnna E. Sloggy, MA, CCC-SLP

Written by JoAnna Sloggy, a speech-language pathologist and singing-voice specialist at the UK Voice & Swallow Clinic.

In the U.S., 7.5 million people have trouble using their voices. We often forget the important role voice plays in our daily lives. On Sunday, April 16, World Voice Day is a time to stop and consider the importance of the human voice in every part of our daily lives. World Voice Day aims to celebrate the human voice and raise awareness for voice disorders, vocal health, vocal training and voice research.

What causes voice disorders?

Voice is created by vibration of the vocal folds, and a voice disorder occurs when the vocal folds are unable to vibrate well enough to create a clear vocal sound. A voice disorder may be caused by voice overuse or misuse, neck and throat injuries or growths, and diseases such as cancer or Parkinson’s disease. Voice adds intent, mood and meaning to the words we speak – imagine the interpersonal loss of not being able to express yourself vocally through speech or song.

Most people have experienced temporary vocal problems such as hoarseness or loss of voice due to allergies, colds or cheering too enthusiastically for your favorite team. Usually, voice returns to normal within several days. However, if a voice change lasts for longer than two weeks, the problem should be checked by your doctor.

Be sure to practice vocal hygiene

To keep your voice healthy, follow these vocal hygiene recommendations.

  1. Listen to how your voice sounds. Hoarseness or other voice changes lasting longer than two weeks should be evaluated by a voice care team, such as an otolaryngologist and a speech-language pathologist who specializes in voice disorders.
  2. Stay hydrated. Drink plenty of water to keep your vocal folds and voice box well lubricated.
  3. Quit smoking. Tobacco, nicotine, chemicals, inhaled heat and other substances can cause inflammation and swelling of the voice box and cause cancer in the mouth, nose, throat and lungs.
  4. Avoid screaming, cheering loudly or talking over loud noise. These behaviors cause damage to the vocal fold tissue and strain to the voice muscles.
  5. Limit alcohol and caffeine. These substances have a drying effect on the vocal folds.
  6. Avoid repeated throat clearing and/or coughing. These behaviors can cause vocal damage. Try sipping water and swallowing hard when you have the urge to cough or throat clear.
  7. Manage acid reflux. Stomach acid can damage the tissue of your throat and cause hoarseness and other vocal problems.
  8. Give your voice a rest when recovering from hoarseness. When your vocal folds are swollen and inflamed, there is increased risk of vocal damage. Until your voice returns to normal, avoid straining or forcing your voice.
  9. Give your voice a break. Vocal “naps” are good when your voice is tired from overuse or from talking too loudly.

You are never too young or too old to stop and check your vocal health. Making changes to improve or maintain your good voice habits will benefit your health for years to come. This World Voice Day, take time today to celebrate your voice!

This column is scheduled to run in the Lexington Herald-Leader this weekend.


Next steps:

What you need to know about mumps

What you need to know about mumps

Last week, UK’s University Health Service saw a couple of isolated cases of mumps, a contagious virus whose tell-tale symptom is swelling near the neck and jaw.

Although the overwhelming majority of people who get mumps recover completely, it’s important to know the signs of the virus and what to do if you think you have it.

What is mumps?

Mumps is an illness caused by the mumps virus. It’s easily spread by airborne droplets from the upper respiratory tract.

Mumps typically starts with a few days of fever, headache, fatigue and loss of appetite, followed by swollen salivary glands, or swelling near the neck and jaw. Since the introduction of the mumps vaccine, cases of mumps in the U.S. are uncommon.

What are the symptoms of mumps?

Many children have no symptoms or very mild symptoms. The following are the most common symptoms of mumps that may be seen in both adults and children:

  • Discomfort in the salivary glands (in front of the ears), which may become swollen and tender.
  • Difficulty chewing.
  • Pain and tenderness of the testicles.
  • Fever.
  • Headache.
  • Muscle aches.
  • Tiredness.
  • Loss of appetite.

The symptoms of mumps may look like other conditions or medical problems. Always consult your doctor for a diagnosis.

What should you do if you think you have mumps?

  • UK students: Students who have swollen parotid salivary glands should make an appointment with UHS to be evaluated or see their family physician. Students can go online and make a clinician appointment via the Student Health Link on the LinkBlue/My UK portal or by calling 859-323-APPT (2778) Monday through Friday from 8 a.m. to 5 p.m.
  • UK faculty and staff: If you have symptoms, see your local clinician, or if you can’t get an appointment with your regular clinician and have UK HMO, PPO, or EM, you can call for an appointment at the UK Health Plans Urgent Care Clinic at 859-323-SICK (7425).
  • Non-UK employees: If you’re not a UK employee, but are experiencing symptoms, contact your primary care physician and make an appointment.

If you have any of the symptoms of mumps, avoid prolonged close contact with other people for five days after your salivary glands began to swell. You should not go to work or classes during this period.

In addition to staying away from others, you can help prevent the virus from spreading by covering your mouth and nose with a tissue when you cough or sneeze, washing hands frequently, and wearing a mask if you have to be around others.

What complications are associated with mumps?

Complications of mumps occur more frequently among adults than children, and may include:

  • Meningitis or encephalitis. Inflammation of the membrane that covers the brain and spinal cord or inflammation of the brain.
  • Orchitis. Inflammation of one or both testicles.
  • Mastitis. Inflammation of breast tissue.
  • Oophoritis. Inflammation of one or both ovaries.
  • Pancreatitis. Inflammation of the pancreas.
  • Deafness

How is mumps diagnosed?

In addition to a complete medical history and medical exam, your healthcare provider may also take a swab of the side of your mouth to confirm the diagnosis.

What is the treatment for mumps?

Treatment is usually limited to medications for pain and plenty of fluids. Sometimes bedrest is necessary the first few days. According to the CDC, adults should stay home from work for five days after glands begin to swell. Children should stay out of school until symptoms have subsided. Both adults and children with mumps symptoms should minimize contact with other people who live in their homes. Good basic hygiene practices, such as thorough hand-washing, covering the mouth when sneezing or coughing, and regularly cleaning frequently-touched surfaces, are also important in disease control.

How can mumps be prevented?

The measles, mumps and rubella (MMR) is a childhood combination vaccination against mumps, measles and rubella. The MMR provides immunity for most people. People who have had the mumps are immune for life.

If you have not previously been vaccinated or if you are unsure if you have received two doses of the MMR vaccine, we are recommending that you get vaccinated.

Usually, the first dose of the MMR vaccine is given when a child is 12 to 15 months old, and a second dose is given at 4 to 6 years of age. However, if 28 days have passed since the first dose was given, a second dose may be given before the age of 4.


Next steps:

Specialized research nurses who work with the UK Center for Clinical and Translational Science provide outpatient, inpatient, and off-site care for research participants, along with an array of other research support services.

UK’s clinical research nurses help make discoveries happen

Across the University of Kentucky, clinical research nurses carry out clinical procedures and care for those who participate in research studies. They not only provide the best possible patient care, but they also help make discoveries that advance healthcare altogether.

Research nurses have long been at the heart of health research, but it wasn’t until late 2016 that the American Nurses Association recognized clinical research nursing as nursing specialty practice.

For Linda Rice, a registered nurse and director of clinical operations for the clinical services core (CSC) of the UK Center for Clinical and Translational Science (CCTS), the designation of a clinical nursing specialty for research means a great deal.

“It means a lot to me that my colleagues recognize our specialty – that all the time and effort and years of training are acknowledged by our board and peers,” Rice said. “I’ve enjoyed seeing my profession grow, and knowing that the decisions we make to take care of our patients are based on evidence-based research. It does take nurses to conduct successful clinical research, and they have to specifically trained – it’s a body of knowledge and experience.”

Working across medical specialties

Rice oversees a team of nurses who assist in conducting research in the CCTS inpatient and outpatient research units for adults and children. They also provide additional clinical research services, such as study coordination.

Over the last three years, the CCTS CSC has averaged between 1,200 and 1,500 inpatient bed-nights per year, 1,600 to 1,800 outpatient days per year, and 500 to 700 offsite visits per year. During this time, the clinical research nursing team has also had to perform increasingly complex tasks, such as euglycemic clamps, oral glucose tolerance tests, muscle/bone biopsies, a wide variety of infusions (like monoclonal antibodies and immunotherapies), pediatric care and off-site care.

In total, about 56 research nurses work in research across medical specialties at UK, such as cancer, neurology, surgery, neonatology/pediatrics, cardiology, behavior science and substance use disorders, emergency care, and infectious diseases.

‘Research is the hope of the future’

Rice entered the field after encountering research nursing in her undergraduate training. Hoping to use this aspect of her education, she applied for a research coordinator job. The possibility of finding ways to improve patient care has motivated her work for nearly three decades.

“I love being on the cutting edge,” she said. “I love knowing, as a nurse, what other things are out there that are being trialed to improve care for patients. I was drawn to this profession because I wanted to help people. And what better way than to be on the front end of trying to make things better? Someone told me once that without research, there is no hope. Research is the hope of the future for better health. And to help facilitate that is such a reward.”

The primary task is the same in research nursing as in standard clinical nursing: to care for people, in this case research participants. But research nurses must possess a repertoire of knowledge and skills far beyond clinical practice. They must also know the complex tiers of institutional and federal regulations that govern health research in general, as well as the intricate protocols and diverse clinical skills required by each specific research study.

No two days are alike

Kathy Holbrook is a registered nurse and is a clinical research coordinator who also works with the CCTS. She’s been a research nurse for 13 years but said that when she started in the field, she didn’t know exactly what she was getting into.

“I learned as I went along,” she said. “But you’re still a nurse first. That means you’re ensuring the health and safety of whomever you’re taking care of. For me, it’s research volunteers.”

Holbrook finds the her work in research nursing to be invigorating and appreciates that no two days are ever alike. At any given time she might be working on several research studies in different medical specialties that require her to perform an array of tasks.

“We do a lot of data collection and we make a lot of observations to support the thesis of the protocol,” Holbrook said. “We educate our participants and volunteers on what it means to be a participant in research. And research protocols have you do procedures you might not often do in bedside or clinic nursing. The variety is endless, and that’s one of the things that keeps it fresh and interesting.”

Working closely with study volunteers and researchers is another highlight of the job, Holbrook said.

“It’s very heartwarming to know that people are willing to give of themselves for altruistic reasons,” she said. “And in working with the researchers, we get to see people being creative and thinking outside of the box to really look at something differently and ask how we can do something better.”


Next steps:

  • Researchers are working hard to identify new treatments and strategies to improve health, but they need healthy participants and those with medical conditions to participate in clinical studies. Find out how you can participate in clinical research at UK HealthCare.
  • Learn more about the groundbreaking translational research happening at UK CCTS.
UK HealthCare earns designation for high-quality LGBTQ patient care

UK HealthCare recognized for providing discrimination-free care to LGBTQ community

UK HealthCare has been named a Healthcare Equality Index Leader for its efforts in delivering high-quality care to all patients, especially those in the lesbian, gay, bisexual, transgender and queer (LGBTQ) community.

The Human Right Campaign Foundation, the largest national LGBTQ civil rights advocacy group, awards this designation to healthcare facilities that “meet a deep and urgent need on the part of lesbian, gay, bisexual and transgender Americans: the need for equitable, knowledgeable  and welcoming healthcare, free from discrimination.”

Equality is demonstrated in policy development, best practices and education of the workforce as integral components of the patient care environment and culture.

To ensure that we continue along this path, a team at UK HealthCare works tirelessly to review policies, patient materials and the UK HealthCare website for inclusive language. The team also continues to explore innovative methods to educate our providers and staff about caring for LGBTQ patients and their families.

To date, numerous policies have been either created or updated to reflect inclusive language around areas such as gender identity, sexual orientation and gender expression. Key areas of focus with policy development include healthcare surrogates, visitation policy, end-of-life care, patient consent and bed placement of transgender patients.

Other areas of focus to strengthen our commitment to equal, safe patient care for all include:

  • Development of the Transform Health Clinic, which provides care for LGBTQ patients with an emphasis on the unique needs of transgender patients;
  • Employee benefit expansion to include coverage for gender confirming surgery along with hormone replacement therapy; and
  • A campuswide assessment and signage for all single-stall restrooms for improved privacy.

We’re proud to be named a Healthcare Equality Index Leader, and we will continue to be committed to lifting the bar of excellence and challenging ourselves to be better. We will continue to not only be an example, but to set the example as leaders in providing safe, quality and equitable care to all people from all backgrounds in the Commonwealth and beyond.


Next steps:

UK Albert B. Chandler Hospital

Chandler Hospital named among 100 Great Hospitals in America

UK Albert B. Chandler Hospital has been named among the 100 Great Hospitals in America by Becker’s Hospital Review, a monthly publication offering business and legal news and analysis relating to hospitals and health systems.

The hospitals included on this list are renowned for excellence. They are industry leaders in innovation, quality patient care and clinical research, and have received recognition across various publications and accrediting organizations.

Becker’s Hospital Review has published a version of this list since 2012.

The Becker’s Hospital Review editorial team selected hospitals for inclusion based on analysis of several ranking and award agencies, including U.S. News and World Report’s 2016-17 Honor Roll and specialty rankings, CMS star ratings, Leapfrog grades, Truven Health Analytics top hospitals, Most Wired hospitals and Magnet accreditation.

The full list of organizations – presented in alphabetical order – can be read here.


Next steps:

Dr. Matthew Bush

Dr. Matthew Bush honored for work to improve hearing healthcare

Dr. Matthew Bush, a clinician and researcher at UK Otolaryngology, Head & Neck Surgery, was recently awarded a prestigious fellowship for his research related to improving hearing healthcare in underserved rural areas.

Bush is a doctoral candidate in the Department of Behavioral Science at UK. He is one of only 10 recipients nationwide to receive the $10,000 2017 Dissertation Fellowship from The Honor Society of Phi Kappa Phi, the nation’s oldest and most selective collegiate honor society for all disciplines.

His research investigates hearing healthcare disparities in underserved rural populations with a goal to develop and implement innovative interventions that improve the diagnosis and treatment of hearing loss. The fellowship award will be applied toward 12 months of dissertation writing.

Bush received extensive medical training at Marshall University and UK. He studied hearing healthcare, ear surgery and innovative technologies including cochlear implants. He completed his fellowship at the Ohio State University, where he began to develop research on hearing healthcare in rural populations.


Next steps:

  • Get to know Dr. Bush in our Making the Rounds interview. He tells us what his ideal weekend looks like and how he gives the gift of hearing, here and around the world.
  • Learn more about cochlear implants, including who is a candidate for the device and how they’re different from hearing aids.
UK researcher Hefei Wen has authored a study showing state drug-monitoring programs can reduce the number of opioids prescribed to Medicaid recipients.

Monitoring programs can help address opioid epidemic, UK research shows

New research from the UK College of Public Health suggests state drug-monitoring programs are effective in reducing the number of opioids prescribed to Medicaid recipients.

Led by researcher Hefei Wen, the study shows that state requirements for healthcare providers to participate in prescription-drug monitoring programs, or PDMPs, have influenced safer prescribing practices for Medicaid patients. Published in the April edition of Health Affairs, the research suggests state PDMP mandates are linked with reduced opioid prescriptions received by Medicaid patients as well as Medicaid spending on opioid prescriptions by as much as 10 percent.

The analysis done by Wen and her team showed state mandatory registration or use of a PDMP reduced Schedule II opioid prescriptions and spending by 9 to 10 percent between 2011 and 2014. The results suggest programs like these are effective in promoting safer and more contained prescribing of opioids with high potential for abuse and dependence. These implications support PDMP mandates as effective in addressing the opioid epidemic.

Forty-nine states and the District of Columbia have PDMPs in place to help providers identify patients at high risk of misusing or abusing controlled substances. However, the average registration rate across the states is low, and most registered prescribers do not use PDMPs on a consistent basis.

An increasing number of states that have implemented mandates that require providers to register with the monitoring programs and to use program data when prescribing opioids and other controlled substances. For instance, in 2012, legislators in Kentucky passed one of the most comprehensive mandates.

The Kentucky mandate requires prescribers to register with the Kentucky All Schedule Prescription Electronic Reporting System (KASPER). Then, they must query the KASPER system for all first-time prescriptions and a minimum of every 12 months after the first prescription. Similarly strong mandates can help improve participation in PDMPs and fulfill their potential in addressing the opioid epidemic.

Wen is an assistant professor in health management and policy in the UK College of Public Health. Her research leverages economic thinking to inform health care and public safety, with a concentration on behavioral health and drug control policy.


Next steps: